Oftersheim, Germany

Reinhard Heck


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Oftersheim, DE (1990)
  • Eberbach, DE (1998)

Company Filing History:


Years Active: 1990-1998

Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Reinhard Heck in Pharmaceutical Chemistry

Introduction

Reinhard Heck is a notable inventor based in Oftersheim, Germany, contributing significantly to the field of pharmaceutical chemistry. With two patents to his name, Heck's work focuses on the development of novel compounds that have potential applications in drug formulation and therapeutics.

Latest Patents

Heck's latest patents include innovations related to 4-aminopyridazines and methods for preparing them. His research also encompasses drugs containing 6-substituted-4-hydroxytetrahydropyran-2-one derivatives. The first patent presents compounds of a specific structural formula, which features various alkylene and cycloaliphatic hydrocarbon radicals. The detailed chemical compositions he has developed include compounds that can exist as lactones or hydroxy acids, as well as the esters and amides derived from free carboxylic acids. Furthermore, his inventions provide processes for synthesizing these compounds and for creating pharmaceutical compositions inclusive of these innovative compounds.

Career Highlights

Reinhard Heck has established himself as a creative force in pharmaceutical research while working with the renowned Boehringer Mannheim GmbH. His focus on synthesizing complex organic compounds has contributed to advances in medicinal chemistry and therapeutic options.

Collaborations

Throughout his career, Heck has collaborated with esteemed professionals such as Wolfgang Von Der Saal and Ralf Kucznierz. These collaborations have enhanced the breadth of innovation and research, further establishing a collaborative spirit within the field.

Conclusion

Reinhard Heck's contributions to pharmaceutical chemistry through his patents reflect his innovative mindset and dedication to developing novel compounds. His partnership with colleagues and his role at Boehringer Mannheim GmbH underscore the importance of collaboration in driving advancements in drug development and therapeutic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…